Balancing Automated Procedures for Confounding Control with Background Knowledge
暂无分享,去创建一个
[1] S. Merhar,et al. Letter to the editor , 2005, IEEE Communications Magazine.
[2] M Alan Brookhart,et al. Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples. , 2011, American journal of epidemiology.
[3] J. Pearl,et al. Causal diagrams for epidemiologic research. , 1999, Epidemiology.
[4] Sebastian Schneeweiss,et al. Using high‐dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system , 2012, Pharmacoepidemiology and drug safety.
[5] M Alan Brookhart,et al. The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration , 2011, Pharmacoepidemiology and drug safety.
[6] J. Robins. Data, Design, and Background Knowledge in Etiologic Inference , 2001, Epidemiology.
[7] G. Shaw,et al. Maternal pesticide exposure from multiple sources and selected congenital anomalies. , 1999 .
[8] R. Platt,et al. The new Sentinel Network--improving the evidence of medical-product safety. , 2009, The New England journal of medicine.
[9] C. O'Connell,et al. The TEMPI syndrome--a novel multisystem disease. , 2011, The New England journal of medicine.
[10] Jun Liu,et al. Studies with Many Covariates and Few Outcomes: Selecting Covariates and Implementing Propensity-Score–Based Confounding Adjustments , 2014, Epidemiology.
[11] J. Pearl. Causality: Models, Reasoning and Inference , 2000 .
[12] J. Myers,et al. Effects of adjusting for instrumental variables on bias and precision of effect estimates. , 2011, American journal of epidemiology.
[13] W. Ray,et al. Population-based studies of adverse drug effects. , 2003, The New England journal of medicine.
[14] J. Rassen,et al. Simultaneously assessing intended and unintended treatment effects of multiple treatment options: a pragmatic “matrix design” , 2011, Pharmacoepidemiology and drug safety.
[15] J. Pearl. Invited commentary: understanding bias amplification. , 2011, American journal of epidemiology.
[16] S. Schneeweiss,et al. Practice of Epidemiology Implications of M Bias in Epidemiologic Studies: a Simulation Study , 2022 .
[17] J. Avorn,et al. High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data , 2009, Epidemiology.
[18] M. Hernán,et al. Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. , 2002, American journal of epidemiology.
[19] W. Ray,et al. Use of disease risk scores in pharmacoepidemiologic studies , 2009, Statistical methods in medical research.
[20] J. Avorn,et al. A review of uses of health care utilization databases for epidemiologic research on therapeutics. , 2005, Journal of clinical epidemiology.
[21] J. Rassen,et al. Re: Confounding adjustment via a semi-automated high-dimensional propensity score algorithm: an application to electronic medical records. , 2011, Pharmacoepidemiology and drug safety.
[22] Sengwee Toh,et al. Confounding adjustment via a semi‐automated high‐dimensional propensity score algorithm: an application to electronic medical records , 2011, Pharmacoepidemiology and drug safety.
[23] Judea Pearl,et al. Comment on ‘Causal inference, probability theory, and graphical insights’ by Stuart G. Baker , 2013, Statistics in medicine.